English
Segment disclosures
Company overviewJUPITER NEUROSCIENCES, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 4 retained observations 3 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Premium Nutritional Supplements · Reportable Geographical Components
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=JUNS:PremiumNutritionalSupplementsMember;srt:ConsolidationItemsAxis=srt:ReportableGeographicalComponentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 24245 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 42897 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 18652 | USD | 20260514 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 21796 | USD | 20260401 | Open filing evidence |